UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heat attack on liver tumors: new combo therapy trial launches
Disease control Not yet recruitingThis study tests whether adding a heat-based therapy (multimodal thermal therapy) to standard targeted therapy and immunotherapy can help people with advanced liver cancer that cannot be removed by surgery. About 166 adults aged 18-80 with unresectable hepatocellular carcinoma wi…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Liver cancer treatment tailored to Tumor's fuel source shows promise in new trial
Disease control Not yet recruitingThis study tests a personalized approach for people with advanced liver cancer that cannot be removed by surgery. Researchers will analyze the tumor's metabolism (how it uses fat for energy) to assign each patient to a specific treatment combination. The goal is to see if this ta…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 18, 2026 12:12 UTC